How is P-21 administered?
This describes how P-21 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a daily schedule, generally over short courses. Specific dosing is individual and beyond general information, and human evidence for P-21 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Daily
- Cycle length: Short courses
- Half-life: ~hours
References
- Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound — Baazaoui N, Iqbal K. Alzheimer's Research & Therapy, 2017
- Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound — Baazaoui N, Iqbal K. Biomolecules, 2022
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on P-21
Last updated 2026-06-15.